Evidence map›Paper›PMID 38436766›Full record

ReviewJournal of robotic surgery2024

Revolutionizing urology: the advancements and applications of robotic platforms.

Kinju Adhikari, Gowtham Krishna Penmetsa, Deepak Krishnappa, Ravi Taori, S K Raghunath

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of robotic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Translational andrology and urology · 2026
    Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kinju AdhikariDepartment of Uro Oncology and Robotic Surgery, HCG Cancer Center, Bengaluru, India.
Gowtham Krishna PenmetsaDepartment of Uro Oncology and Robotic Surgery, HCG Cancer Center, Bengaluru, India.
Deepak KrishnappaDepartment of Uro Oncology and Robotic Surgery, HCG Cancer Center, Bengaluru, India.
Ravi TaoriDepartment of Uro Oncology and Robotic Surgery, HCG Cancer Center, Bengaluru, India.
S K RaghunathDepartment of Uro Oncology and Robotic Surgery, HCG Cancer Center, Bengaluru, India. drraghunathsk@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Robot-assisted surgery is developing as an acme of minimally invasive surgery, given its utmost dominance over laparoscopic surgery. The objective was to review the status of robotic surgery in urological practice with its advantages and disadvantages in current scenario. We conducted a literature search using MEDLINE and identified 72 articles which were relevant to urology. Single-port and various multiport robotic platforms like Da Vinci, Versius, Hugo RAS, Revo-I, Senhance, Mantra, Avatera, Hinotori, and MicroSurge are described with pros and cons. With a surge in different medical surgical robots purging into the market and a race to become the next standard of care in robotic surgery, it is only a matter of time when robotic surgery becomes financially comparable to laparoscopic surgeries.

Indexed as

RoboticsRobotic Surgical ProceduresUrologyHumansDa VinciRobotic advancementRobotic surgical systemRobotic urology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.